56 Followers on Owler

eMolecules

eMolecules is a California-based E-procurement platform that delivers chemicals and bioreagents to pharmaceutical companies. Read more

Niko Gubernator's photo - CEO of eMolecules

CEO

Niko Gubernator

CEO Approval Rating

79/100

Founded:

2005

Status:

PrivateIndependent Company

EMOLECULES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

MolPort is the top competitor of eMolecules. MolPort is a Private company that was founded in Riga, Riga (city) in 2006. Like eMolecules, MolPort also operates in the Specialty Chemicals sector. MolPort has 5 more employees vs. eMolecules.

ZAGENO is seen as one of eMolecules's biggest rivals. ZAGENO was founded in Boston, Massachusetts} in 2015. Like eMolecules, ZAGENO also competes in the Specialty Chemicals space. Compared to eMolecules, ZAGENO generates $25.8M less revenue.

Chemspace is perceived as one of eMolecules's biggest rivals. Chemspace was founded in null, and is headquartered in Monmouth Junction, New Jersey. Like eMolecules, Chemspace also operates in the Specialty Chemicals space. Chemspace generates $ less revenue vs. eMolecules.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 40 a good estimate for eMolecules's Employee count?

eMolecules Acquisitions

No recent acquisitions found related to eMolecules

eMolecules Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Equity Round
Mar 2021
--

Avista Capital Partners

Since eMolecules was founded in 2005, it has participated in 1 round of funding. In total eMolecules has raised $0. eMolecules' funding round was on Mar 2021 for a total of $0

eMolecules Investments

No recent investments found related to eMolecules

eMolecules News

November 1, 2018FinanzNachrichten

eMolecules strengthens its strategic customer and supplier relationship teams

SAN DIEGO, Nov. 1, 2018 /PRNewswire/ -- eMolecules is pleased to announce the addition of three new m... See more »
October 30, 2018FinanzNachrichten

eMolecules strengthens and re-structures its Board through the appointment of two new members

SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- eMolecules is pleased to announce the addition of two new me... See more »
January 12, 2017BioPortfolio

Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop

Combines eMolecules' collection of commercially available chemicals with StarDrop's data analysis and... See more »
April 15, 2016Manufacturing Chemist

eMolecules and World Fusion partner to advance drug discovery

Partnership both extends eMolecules reach into the Japanese market and further empowers US and Europe... See more »

eMolecules Press Releases

Social Media

eMolecules Headquarters

3430 Carmel Mountain Road Suite 250

San Diego, California92121

858-764-1941

Driving Directions »

Trending Companies

eMolecules Summary

ABOUT

Overview

eMolecules is a California-based E-procurement platform that delivers chemicals and bioreagents to pharmaceutical companies. eMolecules was founded in 2005. eMolecules' headquarters is located in San Diego, California, USA 92121. It has raised undiscl...

CEO

eMolecules's CEO, Niko Gubernator, currently has an approval rating of 79%. eMolecules's primary competitors are MolPort, ZAGENO & Chemspace.

Frequently Asked Questions about eMolecules

  1. When was eMolecules founded?

    eMolecules was founded in 2005
  2. Who is eMolecules's CEO?

    eMolecules's CEO is Niko Gubernator
  3. How much revenue does eMolecules generate?

    eMolecules generates $26.8M in revenue
  4. How much funding does eMolecules have?

    eMolecules has historically raised $0 in funding
  1. Where is eMolecules's headquarters?

    eMolecules's headquarters is in San Diego California, USA
  2. How many employees does eMolecules have?

    eMolecules has 40 employees
  3. What sector does eMolecules operate in?

    eMolecules is in Specialty Chemicals
  4. Who are eMolecules's competitors?

    eMolecules's top competitors are MolPort, ZAGENO, Chemspace